CSF2 and cancer: Our study reveals that SIRPγ enriched in CSLCs is a key mediator to maintain CD47 expression both in CSLCs and bulk cancer cells by inducing expression and secretion of IL-1β and GM-CSF from CSLCs in a YAP-dependent manner, offering mechanistic insight into how CD47 expression is orchestrated during cancer progression.